We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Oncology Biosimilars industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
mAb
Immunomodulators
Hematopoietic Agents
G-CSF
Others
Market Segment by Product Application
Retail Pharmacies
Hospital Pharmacy
Online Pharmacy
Finally, the report provides detailed profile and data information analysis of leading company.
Celltrion
Biocon
Dr. Reddy's Laboratories
STADA Arzneimittel AG
Intas Pharmaceuticals
Pfizer
Sandoz International
Teva Pharmaceutical Industries Ltd
Apotex
BIOCAD
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Oncology Biosimilars consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Oncology Biosimilars market by identifying its various subsegments.
3.Focuses on the key global Oncology Biosimilars manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Oncology Biosimilars with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Oncology Biosimilars submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Oncology Biosimilars Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Oncology Biosimilars Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Oncology Biosimilars Segment by Type
2.1.1 mAb
2.1.2 Immunomodulators
2.1.3 Hematopoietic Agents
2.1.4 G-CSF
2.1.5 Others
2.2 Market Analysis by Application
2.2.1 Retail Pharmacies
2.2.2 Hospital Pharmacy
2.2.3 Online Pharmacy
2.3 Global Oncology Biosimilars Market Comparison by Regions (2017-2027)
2.3.1 Global Oncology Biosimilars Market Size (2017-2027)
2.3.2 North America Oncology Biosimilars Status and Prospect (2017-2027)
2.3.3 Europe Oncology Biosimilars Status and Prospect (2017-2027)
2.3.4 China Oncology Biosimilars Status and Prospect (2017-2027)
2.3.5 Japan Oncology Biosimilars Status and Prospect (2017-2027)
2.3.6 Southeast Asia Oncology Biosimilars Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Oncology Biosimilars Industry Impact
2.5.1 Oncology Biosimilars Business Impact Assessment - Covid-19
2.5.2 Market Trends and Oncology Biosimilars Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Oncology Biosimilars Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Oncology Biosimilars Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Oncology Biosimilars Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Oncology Biosimilars Manufacturer Market Share
3.5 Top 10 Oncology Biosimilars Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Oncology Biosimilars Market
3.7 Key Manufacturers Oncology Biosimilars Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Oncology Biosimilars Industry Key Manufacturers
4.1 Celltrion
4.1.1 Compan Detail
4.1.2 Celltrion Oncology Biosimilars Product Introduction, Application and Specification
4.1.3 Celltrion 130 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Celltrion News
4.2 Biocon
4.2.1 Compan Detail
4.2.2 Biocon Oncology Biosimilars Product Introduction, Application and Specification
4.2.3 Biocon Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Celltrion News
4.3 Dr. Reddy's Laboratories
4.3.1 Compan Detail
4.3.2 Dr. Reddy's Laboratories Oncology Biosimilars Product Introduction, Application and Specification
4.3.3 Dr. Reddy's Laboratories Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Dr. Reddy's Laboratories News
4.4 STADA Arzneimittel AG
4.4.1 Compan Detail
4.4.2 STADA Arzneimittel AG Oncology Biosimilars Product Introduction, Application and Specification
4.4.3 STADA Arzneimittel AG Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 STADA Arzneimittel AG News
4.5 Intas Pharmaceuticals
4.5.1 Compan Detail
4.5.2 STADA Arzneimittel AG Oncology Biosimilars Product Introduction, Application and Specification
4.5.3 Intas Pharmaceuticals Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Intas Pharmaceuticals News
4.6 Pfizer
4.6.1 Compan Detail
4.6.2 Pfizer Oncology Biosimilars Product Introduction, Application and Specification
4.6.3 Pfizer Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Pfizer News
4.7 Sandoz International
4.7.1 Compan Detail
4.7.2 Sandoz International Oncology Biosimilars Product Introduction, Application and Specification
4.7.3 Sandoz International Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Teva Pharmaceutical Industries Ltd
4.8.1 Compan Detail
4.8.2 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Product Introduction, Application and Specification
4.8.3 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Teva Pharmaceutical Industries Ltd News
4.9 Apotex
4.9.1 Compan Detail
4.9.2 Apotex Oncology Biosimilars Product Introduction, Application and Specification
4.9.3 Apotex Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Apotex News
4.10 BIOCAD
4.10.1 Compan Detail
4.10.2 BIOCAD Oncology Biosimilars Product Introduction, Application and Specification
4.10.3 BIOCAD Oncology Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 BIOCAD News
5 Global Oncology Biosimilars Market Segment by Big Type
5.1 Global Oncology Biosimilars Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Oncology Biosimilars Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Oncology Biosimilars Revenue and Market Share by Big Type (2017-2022)
5.2 mAb Sales Growth Rate and Price
5.2.1 Global mAb Sales Growth Rate (2017-2022)
5.2.2 Global mAb Price (2017-2022)
5.3 Immunomodulators Sales Growth Rate and Price
5.3.1 Global Immunomodulators Sales Growth Rate (2017-2022)
5.3.2 Global Immunomodulators Price (2017-2022)
5.4 Hematopoietic Agents Sales Growth Rate and Price
5.4.1 Global Hematopoietic Agents Sales Growth Rate (2017-2022)
5.4.2 Global Hematopoietic Agents Price (2017-2022)
5.5 G-CSF Sales Growth Rate and Price
5.5.1 Global G-CSF Sales Growth Rate (2017-2022)
5.5.2 Global G-CSF Price (2017-2022)
5.6 Others Sales Growth Rate and Price
5.6.1 Global Others Sales Growth Rate (2017-2022)
5.6.2 Global Others Price (2017-2022)
6 Global Oncology Biosimilars Market Segment by Big Application
6.1 Global Oncology Biosimilars Sales Market Share by Big Application (2017-2022)
6.2 Retail Pharmacies Sales Growth Rate (2017-2022)
6.3 Hospital Pharmacy Sales Growth Rate (2017-2022)
6.4 Online Pharmacy Sales Growth Rate (2017-2022)
7 Global Oncology Biosimilars Forecast
7.1 Global Oncology Biosimilars Revenue, Sales and Growth Rate (2022-2027)
7.2 Oncology Biosimilars Market Forecast by Regions (2022-2027)
7.2.1 North America Oncology Biosimilars Market Forecast (2022-2027)
7.2.2 Europe Oncology Biosimilars Market Forecast (2022-2027)
7.2.3 China Oncology Biosimilars Market Forecast (2022-2027)
7.2.4 Japan Oncology Biosimilars Market Forecast (2022-2027)
7.2.5 Southeast Asia Oncology Biosimilars Market Forecast (2022-2027)
7.2.6 Other Regions Oncology Biosimilars Market Forecast (2022-2027)
7.3 Oncology Biosimilars Market Forecast by Type (2022-2027)
7.3.1 Global Oncology Biosimilars Sales Forecast by Type (2022-2027)
7.3.2 Global Oncology Biosimilars Market Share Forecast by Type (2022-2027)
7.4 Oncology Biosimilars Market Forecast by Application (2022-2027)
7.4.1 Global Oncology Biosimilars Sales Forecast by Application (2022-2027)
7.4.2 Global Oncology Biosimilars Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Oncology Biosimilars Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Oncology Biosimilars Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Oncology Biosimilars
Figure Market Concentration Ratio and Market Maturity Analysis of Oncology Biosimilars
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Oncology Biosimilars Market Size by Big Type
Figure Global Market Share of Oncology Biosimilars by Big Type in 2021
Figure mAb Picture (2017-2022)
Figure Immunomodulators Picture (2017-2022)
Figure Hematopoietic Agents Picture (2017-2022)
Figure G-CSF Picture (2017-2022)
Global Oncology Biosimilars Market Size by Big Application
Table Global Oncology Biosimilars Market Size by Application
Figure Global Oncology Biosimilars Market Share by Big Application in 2021
Figure Retail Pharmacies Picture
Figure Hospital Pharmacy Picture
Figure Online Pharmacy Picture
Table Global Oncology Biosimilars Comparison by Regions (M USD) ?2017-2027?
Figure Global Oncology Biosimilars Market Size (Million US$) (2017-2027)
Figure North America Oncology Biosimilars Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Oncology Biosimilars Revenue (Million US$) Growth Rate (2017-2027)
Figure China Oncology Biosimilars Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Oncology Biosimilars Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Oncology Biosimilars Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Oncology Biosimilars Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Oncology Biosimilars Sales by Manufacturer (2017-2022)
Figure Global Oncology Biosimilars Sales Market Share by Manufacturer in 2021
Table Global Oncology Biosimilars Revenue by Manufacturer (2017-2022)
Figure Global Oncology Biosimilars Revenue Market Share by Manufacturer in 2021
Table Global Oncology Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Oncology Biosimilars Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Oncology Biosimilars Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Oncology Biosimilars Market
Table Key Manufacturers Oncology Biosimilars Product Type
Table Mergers & Acquisitions Planning
Table Celltrion Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Celltrion
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Biocon Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Biocon
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biocon Recent Development
Table Dr. Reddy's Laboratories Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Dr. Reddy's Laboratories
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Dr. Reddy's Laboratories Main Business
Table Dr. Reddy's Laboratories Recent Development
Table STADA Arzneimittel AG Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of STADA Arzneimittel AG
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table STADA Arzneimittel AG Main Business
Table STADA Arzneimittel AG Recent Development
Table STADA Arzneimittel AG Main Business
Table STADA Arzneimittel AG Recent Development
Table Intas Pharmaceuticals Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Intas Pharmaceuticals
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Intas Pharmaceuticals Main Business
Table Intas Pharmaceuticals Recent Development
Table Pfizer Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Pfizer
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Table Sandoz International Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Sandoz International
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sandoz International Main Business
Table Sandoz International Recent Development
Table Teva Pharmaceutical Industries Ltd Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Teva Pharmaceutical Industries Ltd
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Pharmaceutical Industries Ltd Main Business
Table Teva Pharmaceutical Industries Ltd Recent Development
Table Apotex Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of Apotex
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Apotex Main Business
Table Apotex Recent Development
Table BIOCAD Company Profile
Table Oncology Biosimilars Product Introduction, Application and Specification of BIOCAD
Table Oncology Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table BIOCAD Main Business
Table BIOCAD Recent Development
Figure Global Oncology Biosimilars Sales and Growth Rate (2017-2022)
Figure Global Oncology Biosimilars Revenue and Growth Rate (2017-2022)
Table Global Oncology Biosimilars Sales by Regions (2017-2022)
Figure Global Oncology Biosimilars Sales Market Share by Regions in 2021
Table Global Oncology Biosimilars Revenue by Regions (2017-2022)
Figure Global Oncology Biosimilars Revenue Market Share by Regions in 2021
Figure North America Oncology Biosimilars Sales and Growth Rate (2017-2022)
Figure Europe Oncology Biosimilars Sales and Growth Rate (2017-2022)
Figure China Oncology Biosimilars Sales and Growth Rate (2017-2022)
Figure Japan Oncology Biosimilars Sales and Growth Rate (2017-2022)
Figure Southeast Asia Oncology Biosimilars Sales and Growth Rate (2017-2022)
Figure Other Regions Oncology Biosimilars Sales and Growth Rate (2017-2022)
Table Global Oncology Biosimilars Sales by Big Type (2017-2022)
Table Global Oncology Biosimilars Sales Market Share by Big Type (2017-2022)
Figure Global Oncology Biosimilars Sales Market Share by Big Type in 2019
Table Global Oncology Biosimilars Revenue by Big Type (2017-2022)
Table Global Oncology Biosimilars Revenue Market Share by Big Type (2017-2022)
Table Global Oncology Biosimilars Revenue Market Share by Big Type in 2019
Figure Global mAb Sales Growth Rate (2017-2022)
Figure Global mAb Price (2017-2022)
Figure Global Immunomodulators Sales Growth Rate (2017-2022)
Figure Global Immunomodulators Price (2017-2022)
Figure Global Hematopoietic Agents Sales Growth Rate (2017-2022)
Figure Global Hematopoietic Agents Price (2017-2022)
Figure Global G-CSF Sales Growth Rate (2017-2022)
Figure Global G-CSF Price (2017-2022)
Table Global Oncology Biosimilars Sales by Big Application (2017-2022)
Table Global Oncology Biosimilars Sales Market Share by Big Application (2017-2022)
Figure Global Oncology Biosimilars Sales Market Share by Big Application in 2019
Figure Global Retail Pharmacies Sales Growth Rate (2017-2022)
Figure Global Hospital Pharmacy Sales Growth Rate (2017-2022)
Figure Global Online Pharmacy Sales Growth Rate (2017-2022)
Figure Global Oncology Biosimilars Sales and Growth Rate (2022-2027)
Figure Global Oncology Biosimilars Revenue and Growth Rate (2022-2027)
Table Global Oncology Biosimilars Sales Forecast by Regions (2022-2027)
Table Global Oncology Biosimilars Market Share Forecast by Regions (2022-2027)
Figure North America Sales Oncology Biosimilars Market Forecast (2022-2027)
Figure Europe Sales Oncology Biosimilars Market Forecast (2022-2027)
Figure China Sales Oncology Biosimilars Market Forecast (2022-2027)
Figure Japan Sales Oncology Biosimilars Market Forecast (2022-2027)
Figure Southeast Asia Sales Oncology Biosimilars Market Forecast (2022-2027)
Figure Other Regions Sales Oncology Biosimilars Market Forecast (2022-2027)
Table Global Oncology Biosimilars Sales Forecast by Type (2022-2027)
Table Global Oncology Biosimilars Market Share Forecast by Type (2022-2027)
Table Global Oncology Biosimilars Sales Forecast by Application (2022-2027)
Table Global Oncology Biosimilars Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Oncology Biosimilars Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Oncology Biosimilars Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Oncology Biosimilars Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Oncology Biosimilars Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Oncology Biosimilars Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Oncology Biosimilars Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Oncology Biosimilars Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Oncology Biosimilars Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Celltrion
Biocon
Dr. Reddy's Laboratories
STADA Arzneimittel AG
Intas Pharmaceuticals
Pfizer
Sandoz International
Teva Pharmaceutical Industries Ltd
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)